Clinical trial
Clinical Study of Individualized Vancomycin Dosing Based on Population Pharmacokinetic Model for Severe Infections
NCT06161870 is registered in ClinicalTrials.gov with Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Individualized Vancomycin Dosing Based on Population Pharmacokinetic Model for Severe Infections
- Lead sponsor
- Central South University
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 1, 2021
- Completion date
- December 31, 2024
- Enrollment
- 112 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe infection